Menu Back toSession-3-Track-2A-Personalized-Medicine-Gene-Therapy

Medical Affairs and Scientific Communications Forum

Medical Communication, MSL, and Medical Writing.


Session 11 Track 2B: Personalized Medicine: Gene Therapy

    Session Chair(s)
      Darryl Zachary L'Heureux, PhD, MPharm, MSc

      Darryl Zachary L'Heureux, PhD, MPharm, MSc

      • Medical Writing Manager
      • Bristol-Myers Squibb, United States
    You will leave this session with a basic understanding of what gene therapy is, how gene therapy works, and the challenges associated with education and awareness in the gene therapy space.
    Learning Objective : At the conclusion of this session, participants should be able to:
    • Differentiate between basic types of gene therapy
    • Explain how gene therapy works using simple terms
    • Describe the key challenges associated with educating audiences about gene therapy
    • Identify key insights regarding the straightforward communication of complex science
    Speaker(s)
      Kendra  Bolt, PhD

      AAV Gene Therapies for Rare Diseases

      Kendra Bolt, PhD

      • Manager of Scientific Communications
      • Audentes Therapeutics, United States